CVKD

CADRENAL THERAPEUTICS INC

CVKD·127636207·US·Common Stock·Healthcare - Biotechnology-13D/G

CVKD (CADRENAL THERAPEUTICS INC) is held by 10 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($167,458), HRT FINANCIAL LP ($97,000), GEODE CAPITAL MANAGEMENT, LLC ($63,540). Net institutional sentiment: Mixed.

10
Holders
$363,974
Total Value
56% (9)
Consensus
5 buying - 4 selling
13F: Insider & Congress: Updated regularly
CVKD

Smart Money Verdict

View all
Loading verdict
Held by 10 funds

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Jul 1, 2026 · Activists Aug 7, 2026 · Congress none

InsiderPXPham Quang XSell $22KJun 29, 2026
InsiderPXPham Quang XSell $28KJun 26, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
50,137(+10.9%)$167,4580.0%-88.12%
17
New
29,055$97,0000.0%-72.75%
30
Decreased
19,024(-12.0%)$63,5400.0%-92.27%
0
Unchanged
8,311$27,7590.0%-88.81%
0
Increased
1,112(+370x)$3,7140.0%-72.83%
15
Increased
706(+606.0%)$2,3580.0%-80.37%
13
Unchanged
300$1,0020.0%-94.66%
0
Unchanged
150$5010.0%-93.22%
0
Unchanged
99$3310.0%-95.07%
0
New
93$3110.0%-72.75%
17
Unchanged
25$840.0%-76.53%
0
Exited
0(-100.0%)$50.0%-58.92%
0
Exited
0(-100.0%)$28,1400.0%-65.07%
0
Exited
0(-100.0%)$31,8750.0%-75.11%
0
CVKDCVKDCADRENAL THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used